STOCK TITAN

GRAIL to Announce Third Quarter 2024 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

GRAIL (Nasdaq: GRAL) has scheduled the release of its third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The company will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET on the same day to discuss the results and business progress. Interested parties can access the live webcast and replay through the investor relations section at investors.grail.com, with registration available at the provided link. Participants are advised to register and join ten minutes before the scheduled start time.

GRAIL (Nasdaq: GRAL) ha programmato il rilascio dei suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato martedì 12 novembre 2024. L'azienda ospiterà un webcast e una conference call alle 13:30 PT / 16:30 ET nello stesso giorno per discutere i risultati e i progressi aziendali. Le parti interessate possono accedere al webcast dal vivo e alla registrazione attraverso la sezione relazioni con gli investitori su investors.grail.com, con registrazione disponibile al link fornito. Si consiglia ai partecipanti di registrarsi e unirsi dieci minuti prima dell'orario di inizio previsto.

GRAIL (Nasdaq: GRAL) ha programado el lanzamiento de sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el martes 12 de noviembre de 2024. La empresa organizará un webcast y una conferencia telefónica a la 1:30 p.m. PT / 4:30 p.m. ET el mismo día para discutir los resultados y el progreso del negocio. Las partes interesadas pueden acceder al webcast en vivo y a la repetición a través de la sección de relaciones con los inversores en investors.grail.com, con registro disponible en el enlace proporcionado. Se aconseja a los participantes registrarse y unirse diez minutos antes de la hora de inicio programada.

GRAIL (Nasdaq: GRAL)은 2024년 11월 12일 화요일 시장 마감 후 2024년 3분기 재무 결과를 발표할 예정입니다. 회사는 같은 날 오후 1시 30분 PT / 오후 4시 30분 ET에 결과와 사업 진행 상황을 논의하기 위한 웹캐스트와 전화 회의를 진행합니다. 관심 있는 분들은 제공된 링크에서 등록할 수 있으며, investors.grail.com의 투자자 관계 섹션을 통해 실시간 웹캐스트와 재생된 내용을 이용할 수 있습니다. 참가자는 예정된 시작 시간 10분 전에 등록하고 참여할 것을 권장합니다.

GRAIL (Nasdaq: GRAL) a prévu de publier ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le mardi 12 novembre 2024. L'entreprise organisera un webcast et une conférence téléphonique à 13h30 PT / 16h30 ET le même jour pour discuter des résultats et des avancées de l'entreprise. Les parties intéressées peuvent accéder au webcast en direct et à la rediffusion via la section des relations avec les investisseurs sur investors.grail.com, avec une inscription disponible via le lien fourni. Les participants sont invités à s'inscrire et à rejoindre dix minutes avant l'heure de début prévue.

GRAIL (Nasdaq: GRAL) hat die Veröffentlichung seiner Finanzergebnisse für das dritte Quartal 2024 nach Börsenschluss für Dienstag, den 12. November 2024, angesetzt. Das Unternehmen wird am gleichen Tag um 13:30 Uhr PT / 16:30 Uhr ET eine Webcast und Telefonkonferenz abhalten, um die Ergebnisse und Fortschritte im Geschäft zu besprechen. Interessierte Parteien können auf den Live-Webcast und die Aufnahme über den Bereich für Investoren auf investors.grail.com zugreifen, wobei eine Registrierung über den bereitgestellten Link möglich ist. Die Teilnehmer werden gebeten, sich zehn Minuten vor dem geplanten Startzeitpunkt zu registrieren und zuzuschalten.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., Oct. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2024 following the close of market on Tuesday, Nov. 12, 2024. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and business progress.

Third Quarter 2024 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com

Please register for the live event at https://grail-q3-financial-results-2024.open-exchange.net/.

To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-third-quarter-2024-financial-results-302290446.html

SOURCE GRAIL, Inc.

FAQ

When will GRAIL (GRAL) release Q3 2024 earnings?

GRAIL (GRAL) will release its Q3 2024 financial results after market close on Tuesday, November 12, 2024.

What time is GRAIL's (GRAL) Q3 2024 earnings call?

GRAIL's Q3 2024 earnings call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET on November 12, 2024.

How can I access GRAIL's (GRAL) Q3 2024 earnings webcast?

The earnings webcast can be accessed through GRAIL's investor relations website at investors.grail.com or by registering at the provided link.

GRAIL, Inc.

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Stock Data

504.53M
31.00M
13.75%
66.53%
11.38%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MENLO PARK